{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:05:36Z","timestamp":1774793136181,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jaad.2006.02.033","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T07:19:02Z","timestamp":1148023142000},"page":"992-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis"],"prefix":"10.1016","volume":"54","author":[{"given":"Zhu","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-F.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-W.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-L.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Y.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-S.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-P.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.02.033_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archderm.135.5.546","article-title":"Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib2","first-page":"1517","article-title":"[The pathogenesis of psoriasis\u2014investigating the genetics of a multifactorial disease.]","volume":"119","author":"Asumalahti","year":"2003","journal-title":"Duodecim"},{"key":"10.1016\/j.jaad.2006.02.033_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2133.1995.tb02696.x","article-title":"Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro","volume":"133","author":"Leigh","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1523-1747.2003.12055.x","article-title":"Identification of a commonly used CDR3 region of infiltrating T cells expressing Vbeta13 and Vbeta15 derived from psoriasis patients","volume":"120","author":"Hwang","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib5","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3360::AID-IMMU3360>3.0.CO;2-G","article-title":"Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris","volume":"29","author":"Prinz","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2005.01.001","article-title":"HLA DR B1\u221704, \u221707-restricted epitopes on keratin 17 for autoreactive T cells in psoriasis","volume":"38","author":"Shen","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2006.02.033_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401002502","article-title":"T-cell receptor binding kinetics in T-cell development and activation","author":"Gascoigne","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.jaad.2006.02.033_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.iy.12.040194.002213","article-title":"Antigen analogs\/MHC complexes as specific T cell receptor antagonists","volume":"12","author":"Sette","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/368215a0","article-title":"Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide","volume":"368","author":"Stern","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2006.02.033_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(93)90306-B","article-title":"Promiscuous and allele-specific anchors in HLA-DR-binding peptides","volume":"74","author":"Hammer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2006.02.033_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaad.2006.02.033_bib12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","article-title":"ProPred: prediction of HLA-DR binding sites","volume":"17","author":"Singh","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaad.2006.02.033_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI4238","article-title":"Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody","volume":"102","author":"Kuwana","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2006.02.033_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2133.2001.04469.x","article-title":"Purification of natural antikeratin autoantibodies from normal human serum and their effect on human keratinocytes cultured in vitro","volume":"145","author":"Li","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/eji.200324669","article-title":"Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide","volume":"34","author":"Petersen","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib16","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2006.02.033_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0366-077X.2004.05950.x","article-title":"The use of ciclosporin in psoriasis: a clinical review","volume":"150","author":"Ho","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib18","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.139.11.1433","article-title":"HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris","volume":"139","author":"Skov","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggest a primary immune, but not keratinocyte pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2006.02.033_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1365-3083.1997.d01-438.x","article-title":"Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins","volume":"45","author":"Sigmundsdottir","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2133.1993.tb00224.x","article-title":"Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions","volume":"128","author":"Baker","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-5699(95)80132-4","article-title":"Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigens?","volume":"16","author":"Valdimarsson","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaad.2006.02.033_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200203030-00003","article-title":"Novel therapies for psoriasis","volume":"3","author":"Cather","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/eji.1830220415","article-title":"Interferon-\u03b3 regulates expression of a novel keratin class I gene","volume":"22","author":"Flohr","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1523-1747.ep12613492","article-title":"Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma","volume":"104","author":"Bonnekoh","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib28","first-page":"659","article-title":"The impacts of keratin 17 on the excretion of IFN-\u03b3 and the proliferation of T lymphocytes from psoriatic patients","volume":"37","author":"Shen","year":"2004","journal-title":"Chin J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.033_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.14.1.1","article-title":"Altered peptide ligand induced partial T cell activation: molecular mechanisms and role in T cell biology","volume":"14","author":"Sloan-Lancaster","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2370.1997.00263.x","article-title":"Altered peptide ligands: prospects for immune intervention in autoimmune disease","volume":"24","author":"Fairchild","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaad.2006.02.033_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1074-7613(00)80178-8","article-title":"A functional hot spot for antigen recognition in a superagonist TCR\/MHC complex","volume":"12","author":"Degano","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2006.02.033_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1074-7613(00)80080-1","article-title":"Four A6-TCR \/peptide\/HLA-A2 structures that generate very different T cell signals are nearly identical","volume":"11","author":"Ding","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2006.02.033_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/smim.1996.0011","article-title":"Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T cell activation","volume":"8","author":"Madrenas","year":"1996","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0952-7915(01)00298-9","article-title":"The specificity of TCR\/pMHC interaction","volume":"14","author":"Rudolph","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaad.2006.02.033_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/369407a0","article-title":"Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells","volume":"369","author":"Bertoletti","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2006.02.033_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/369403a0","article-title":"Cytotoxic T cell activity antagonized by naturally occurring HIV-1 Gag variants","volume":"369","author":"Klenerman","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2006.02.033_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2006.02.033_bib38","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1073\/pnas.0409549102","article-title":"Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis","volume":"102","author":"Ben-David","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2006.02.033_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0923-1811(03)00107-5","article-title":"Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris","volume":"33","author":"Doi","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2006.02.033_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s004030050473","article-title":"The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes","volume":"292","author":"Seifert","year":"2000","journal-title":"Arch Dermatol Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206005494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206005494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:03:15Z","timestamp":1759269795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206005494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0190962206005494"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.02.033","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}